Floatz logo

Manganese Superoxide Dismutase Plasmid Liposome

Esophageal

Joel Greenbergergene_therapyPhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Esophageal cohort.

Asset / SponsorPhaseRating
Esomeprazole
Rush University Medical Center
Phase 2CCC
Carboplatin
Joel Greenberger
Phase 1/2CCC

Same molecule, other indications

Manganese Superoxide Dismutase Plasmid Liposome is also rated in:

ToxicityDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →